KXK · Class II · 21 CFR 892.5730

FDA Product Code KXK: Source, Brachytherapy, Radionuclide

Leading manufacturers include Isoaid, LLC and Oncopatch, Inc..

151
Total
151
Cleared
131d
Avg days
1980
Since
Stable submission activity - 2 submissions in the last 2 years
Review times increasing: avg 218d recently vs 129d historically

FDA 510(k) Cleared Source, Brachytherapy, Radionuclide Devices (Product Code KXK)

151 devices
1–24 of 151

About Product Code KXK - Regulatory Context

510(k) Submission Activity

151 total 510(k) submissions under product code KXK since 1980, with 151 receiving FDA clearance (average review time: 131 days).

Submission volume has remained relatively stable over the observed period, with 2 submissions in the last 24 months.

FDA Review Time

Recent submissions under KXK have taken an average of 218 days to reach a decision - up from 129 days historically. Manufacturers should account for longer review timelines in current project planning.

KXK devices are reviewed by the Radiology panel. Browse all Radiology devices →